EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line

Jaime Espinós, José Manuel Aramendía, Antonio González-Martín, Marta Santisteban, Luisa Sánchez, Ángel Vizcay, José Ángel Mínguez, Juan Luis Alcázar

Clinical and Translational Oncology · 2024

DOI: 10.1007/s12094-024-03523-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Jaime Espinós und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Cancer Center Clínica Universidad de Navarra, Universidad de Navarra, Madrid, Spain. jespinos@unav.es. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Neutrophils. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de Navarra.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Various systemic inflammation response indexes (SIRI) have repeatedly been described as prognostic factors in ovarian cancer. They have not been validated in prospective trials and published results are sometimes contradictory. We aimed to explore their role in a cohort of patients diagnosed with stage III and IV ovarian cancer treated at our institution.

Methods

We retrospectively examined the prognostic influence of the neutrophil-to-lymphocyte ratio (NLR), the platelet-to-lymphocyte ratio (PLR), the monocyte-to-lymphocyte ratio (MLR), the red cell distribution width (RDW), and the mean platelet volume (MPV).

Results

A total of 77 patients were analyzed. NLR > 2.243 at diagnosis, NLR before primary surgery, MLR at diagnosis, PLR > 289.1 at diagnosis, and PLR at diagnosis were significant in univariate Cox regression for progression-free survival, but none of them retained their significance in the multivariate Cox regression analysis. For overall survival, NLR > = 2.53 at diagnosis, MLR > = 0.245 at diagnosis, and PLR > = 198.3 at diagnosis resulted significant in univariate COX regression; only PLR > = 198.3 at diagnosis retained its significance in the multivariate analysis.

Conclusion

In our cohort, PLR > = 198.3 was an independent prognostic factor for worse OS. The definitive role of SIRI in ovarian cancer has not yet been established. If their value as prognostic factors could finally be established, they would become a simple and economical method to predict prognosis in patients with advanced ovarian cancer. Therefore, it is time to conduct prospective, multicenter studies with larger samples to definitively establish its role in ovarian cancer, if any.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsNeutrophilsHumansFemaleRetrospective StudiesMiddle AgedPrognosisAgedAdultMonocytesInflammationAged, 80 and overLymphocytesBlood Cell CountErythrocyte IndicesBlood PlateletsMean Platelet VolumeProportional Hazards ModelsLymphocyte Count

Stichwörter der Autor:innen

Mean platelet volume (MPV)Monocyte-to-lymphocyte ratio (MLR)Neutrophil-to-lymphocyte ratio (NLR)Ovarian cancerPlatelet-to-lymphocyte ratio (PLR)Red cell distribution width (RDW)Systemic inflammation response index (SIRI)

Autor:innen und Institutionen

  • Department of Medical Oncology, Cancer Center Clínica Universidad de Navarra, Universidad de Navarra, Madrid, Spain. jespinos@unav.es.
  • Department of Medical Oncology, Cancer Center Clínica Universidad de Navarra, Universidad de Navarra, Pamplona, Spain.
  • Department of Medical Oncology, Cancer Center Clínica Universidad de Navarra, Universidad de Navarra, Madrid, Spain.
  • Department of Obstetrics and Gynecology, Cancer Center Clínica Universidad de Navarra, Universidad de Navarra, Pamplona, Spain.

Förderung

  • Universidad de Navarra

Zitieren

APA

Espinós, J., Aramendía, J. M., González-Martín, A., Santisteban, M., Sánchez, L., Vizcay, Á., Mínguez, J. Á., & Alcázar, J. L. (2024). Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03523-3

Vancouver

Espinós J, Aramendía JM, González-Martín A, Santisteban M, Sánchez L, Vizcay Á, et al. Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03523-3

BibTeX
@article{Espins2024,
  author = {Espinós, Jaime and Aramendía, José Manuel and González-Martín, Antonio and Santisteban, Marta and Sánchez, Luisa and Vizcay, Ángel and Mínguez, José Ángel and Alcázar, Juan Luis},
  title = {Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line},
  journal = {Clinical and Translational Oncology},
  year = {2024},
  doi = {10.1007/s12094-024-03523-3}
}
Kostenlos starten →